BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Hvas CL, Ott P, Paine P, Lal S, Jørgensen SP, Dahlerup JF. Obeticholic acid for severe bile acid diarrhea with intestinal failure: A case report and review of the literature. World J Gastroenterol 2018; 24(21): 2320-2326 [PMID: 29881241 DOI: 10.3748/wjg.v24.i21.2320]
URL: https://www.wjgnet.com/1007-9327/full/v24/i21/2320.htm
Number Citing Articles
R. Yu. Hrytsko, O. M. Bochar, V. T. Bochar. СУЧАСНІ ПОГЛЯДИ НА ХОЛОГЕННУ ДІАРЕЮІнфекційні хвороби 2019; (3): 46 doi: 10.11603/1681-2727.2019.3.10635
Liraglutide/octreotideReactions Weekly 2018; 1709(1): 145 doi: 10.1007/s40278-018-48556-3
Zenta Yasukawa, Ryo Inoue, Makoto Ozeki, Tsutomu Okubo, Tomohisa Takagi, Akira Honda, Yuji Naito. Effect of Repeated Consumption of Partially Hydrolyzed Guar Gum on Fecal Characteristics and Gut Microbiota: A Randomized, Double-Blind, Placebo-Controlled, and Parallel-Group Clinical TrialNutrients 2019; 11(9): 2170 doi: 10.3390/nu11092170
James Morgan, Ashley Bond, Cecil Kullu, Sreedhar Subramanian, Martyn Dibb, Philip J Smith. Managing intestinal failure in inflammatory bowel disease - ‘when the drugs don’t work’Frontline Gastroenterology 2021; 12(5): 414 doi: 10.1136/flgastro-2018-101058
John Y. L. Chiang, Jessica M. Ferrell. Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapyAmerican Journal of Physiology-Gastrointestinal and Liver Physiology 2020; 318(3): G554 doi: 10.1152/ajpgi.00223.2019
Julian R. F. Walters. Letter: long-term treatment of severe bile acid diarrhoea-obeticholic acid can normalise SeHCAT retentionAlimentary Pharmacology & Therapeutics 2018; 48(9): 1032 doi: 10.1111/apt.14979